Target is expanding its intoxicating hemp THC beverage program to more than 300 stores across Florida, Texas and Illinois, just six months before a federal ban that would wipe most of those products off shelves. Either Target’s government affairs team knows something the rest of the industry doesn’t, or the math works even if the ban hits. Either answer is news.
Target just made a strategic bet that’s hard to read. According to BevNet, the retailer is expanding its intoxicating hemp THC beverage program to over 300 stores across three new states, including all locations in Florida and Texas, plus the Illinois stores where local jurisdictions allow it. Brands on shelf reportedly include Cann, Wynk, Trail Magic, Stigma, Gigli and Daizy’s. The expansion follows last fall’s 10-store pilot in the Minneapolis region and a January expansion to 72 additional Minnesota stores.
Six months from now, on November 13, 2026, a provision buried in the spending bill President Donald Trump signed last year is set to redefine federal hemp. After that date, the only legal hemp products will be those containing no more than 0.4 milligrams of total THC per container. Most of what Target just put on shelves wouldn’t survive that cap.
The two facts don’t seem to fit together. Either Target is making an aggressive bet that the November cliff won’t actually land, or it has already done the math on a worst-case scenario and decided to expand anyway. Both readings are interesting.
What a write-down actually looks like
Industry sources report that Target is hedging by planning to mark down its intoxicating hemp inventory in October if no regulatory solution is in place. That’s a write-down. In retail accounting, when a company can no longer sell inventory at full price (or at all), it has to formally reduce its book value to reflect what it can actually recover. The difference between what Target paid wholesale and what it ultimately gets for clearing the shelves is the loss.
For a company of Target’s size, even a multi-million dollar inventory write-down on hemp THC beverages is mathematically negligible. Target generated almost $107 billion in revenue in 2024. A $10 million write-down represents 0.009% of annual revenue. The downside is small enough that the question becomes whether the upside justifies the risk.
The math, scaled
300+
Target stores adding hemp THC drinks across FL, TX, IL
Nov 13
Date federal hemp THC cap of 0.4mg per container takes effect
$107B
Target’s 2024 revenue. A $10M inventory write-down is rounding error.
10mg
Maximum THC per container Target now stocks. Far above the proposed federal cap.
Target isn’t betting that the ban won’t happen. It’s betting that the cost of being wrong is smaller than the cost of being late. Six months of incremental sales, the supplier relationships established, the consumer behavior data captured, and the shelf positioning earned all hold value even if the November cliff arrives on schedule. If it doesn’t arrive, or arrives in modified form, Target is positioned at the front of the category.
Target is not alone
The expansion fits a pattern. Sprouts Farmers Market mainstreamed hemp THC drinks across 120 stores. Circle K added them to convenience-store shelves in allowable states. Beverage alcohol distributor Breakthru Beverage entered the category. Each of these companies has lawyers, government affairs teams and strategic forecasting that tracks Farm Bill negotiations as closely as anyone in Washington. None of them appears to be acting like the November ban is a settled outcome.
The collective behavior of major retailers is a market-level signal. Either they’re collectively misreading the legislative situation, or there’s enough lobbying momentum, regulatory ambiguity or expected delay built into their forecasts that the bet looks defensible. The House passed the Farm Bill on April 30 with the looming hemp ban intact, but lobbying pressure to push the effective date is active and ongoing.
The 280E contradiction nobody is talking about
Here’s the part of the Target story that should land hardest for anyone in the regulated cannabis industry. Target can sell a 10mg THC drink in Florida and Texas, deduct every cost associated with that sale (cost of goods, payroll, rent, marketing, shipping), and pay normal corporate income tax on the profit at 21%. Standard retailer treatment.
A state-licensed adult-use cannabis dispensary selling a chemically similar product (often the same molecule, same dosage, same consumer experience) operates under IRS Section 280E, which prohibits the deduction of any business expense other than cost of goods sold. Marketing, rent, payroll, security, none of it is deductible. Effective federal tax rates routinely land between 60% and 80%, sometimes higher. Operators pay federal income tax on revenue rather than profit, which is precisely why so many state-licensed dispensaries struggle to break even.
The Trump administration’s recent announcement of steps toward rescheduling marijuana from Schedule I to Schedule III would likely address 280E for medical operators. It does nothing for adult-use businesses, which remain fully subject to the provision until federal law changes more substantively. Even after rescheduling, the existing tax inequity between Target’s hemp THC drink program and a licensed dispensary’s adult-use sales remains intact.
Same drug. Same effect. Same consumer. Two completely different regulatory pathways, two completely different tax regimes, two completely different economic outcomes. Target is exploiting the gap. It’s not doing anything wrong. The gap exists because Congress wrote the 2018 Farm Bill in a way that left synthetic and converted hemp cannabinoids in legal ambiguity, and the same Congress now weighing whether to close that gap is also responsible for designing 280E in the first place.
The signal Target is sending
Target isn’t a lobbying force in cannabis policy. It’s stayed quiet through the Farm Bill negotiations and has not joined any of the industry coalitions pushing to delay the November ban. But the expansion itself is a signal. When a $107 billion retailer commits floor space, supplier contracts and category leadership to a product class six months before a federal ban could erase it, lawmakers notice.
The signal is that Target sees a viable, growing consumer market for low-dose THC beverages and is betting that the November cliff either won’t fully land or won’t last. Other retailers are reading the same data and reaching the same conclusion. The regulated cannabis industry, meanwhile, watches a major retailer profit from a product category licensed operators can’t access without paying double the tax rate, even after the rescheduling everyone has been waiting for.
Either Target is wrong about the timing, or the ban isn’t as inevitable as Congress made it sound. Either answer is news. The one that hurts more is the answer to a different question: why does the regulated cannabis industry still have to pay 70% in federal taxes while Target gets to deduct shipping costs on the same molecule?
